CD274 and hepatocellular carcinoma: In the present study, there was a significant difference in PD-L1 expression level in HCC tissues from patients in the high-risk group compared to the low-risk group, suggesting patients with high-risk scores may be candidates for immunotherapy targeting the PD-1/PD-L1 pathway.